CLINICAL SCIENCES. for less than 1% of all malignant eyelid lesions. 1-4 In a survey of
|
|
- Earl McLaughlin
- 5 years ago
- Views:
Transcription
1 CLINICAL SCIENCES Metastatic Tumors to the Eyelid Report of 20 Cases and Review of the Literature Carlos ianciotto, MD; Hakan Demirci, MD; Carol L. Shields, MD; Ralph C. Eagle Jr, MD; Jerry A. Shields, MD Objective: To determine the primary sites, clinical features, treatment, and outcome of 20 patients with cancer metastatic to the eyelids. Methods: Retrospective review of medical records. Results: The primary tumors included skin melanoma (4 [20%]), uveal melanoma (4 [20%]), breast carcinoma and conjunctival melanoma (3 [15%] each), renal cell carcinoma (2 [10%]), and medullary thyroid carcinoma, prostate carcinoma, lung carcinoma, and salivary gland carcinoma (1 [5%] each). Eyelid metastasis was the first sign of systemic cancer in 3 patients (15%). The most common clinical finding at the initial examination was a solitary nodule in 12 patients (60%), a flat pigmented lesion and diffuse eyelid swelling in 3 patients each (15%), and multiple nodules and epiphora in 1 patient (5%) each. Ten patients (50%) had concomitant ocular site metastasis. Primary treatment included excision alone in 6 patients (30%), external beam radiotherapy in 7 (35%), systemic chemotherapy in 4 (20%), and observation in 3 (15%). The metastatic tumors regressed in 10 patients (50%), remained stable in 7 (35%), and showed progression in 3 (15%). After a mean follow-up of 16 months, 9 patients (45%) were alive and 11 (55%) had died of systemic metastatic disease. Conclusions: Eyelid metastasis can display a variety of clinical features and should be considered in patients with known systemic cancer. These patients usually have multiple metastatic sites, ocular and nonocular. The systemic prognosis is poor. Arch Ophthalmol. 2009;127(8): Author Affiliations: Ocular Oncology Service (Drs ianciotto, Demirci, C. L. Shields, and J. A. Shields) and Department of Pathology (Dr Eagle), Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania. METASTASES TO THE EYElids are rare, accounting for less than 1% of all malignant eyelid lesions. 1-4 In a survey of 892 eyelid lesions from an ocular pathology laboratory, Aurora and lodi 1 reported that 214 (24.0%) were malignant. The findings included basal cell carcinoma (172 [19.3%]), squamous cell carcinoma (15 [1.7%]), malignant melanoma (11 [1.2%]), and sebaceous gland carcinoma (7 [0.8%]). There were only 3 cases (0.3%) of eyelid metastasis. Similarly, in a review of 1502 eyelid lesions evaluated histopathologically, Arnold and coworkers 2 found only 1 case (0.07%) of eyelid metastasis. In the ophthalmic literature, information on eyelid metastases has been reported mostly as individual case reports and a few small case series Riley 11 reported 15 cases of eyelid metastasis from a pathology laboratory registry and found that the most common primary tumor was breast carcinoma (6 [40%]), followed by skin melanoma (5 [33%]), gastric carcinoma (2 [13%]), uveal melanoma (1 [7%]), and lung carcinoma (1 [7%]). Later, Mansour and Hidayat 12 reviewed 31 cases from the Armed Forces Institute of Pathology and found that the most frequent primary site was the breast (11 [35%]), followed by the skin (4 [13%]), gastrointestinal tract (3 [10%]), genitourinary tract (3 [10%]), and uvea (2 [6%]). These studies focused primarily on the histopathologic features of eyelid metastases, with little information on the clinical aspects and patient outcomes. In this study, we describe the clinical features, systemic and local treatment, and outcome of 20 patients with eyelid metastasis who were diagnosed and managed at a single ocular oncology center across 3 decades. METHODS We reviewed the medical records of all patients with eyelid metastasis that was managed at the Ocular Oncology Service, Wills Eye Institute, from August 1977 through July
2 A C 40% (a) (a) 10% (b) 45% (c) 10% (b) 25% (a) 15% 15% (d) (c) 10% (d) 15% (b) 35% (c) 5% (d) 40% (e) 25% (f) 10% Figure 1. Location of eyelid metastasis with the percentage of tissue affected in each case. A, Quadrants include the upper eyelid (a), lower eyelid (b), medial canthal area (c), and lateral canthal area (d)., Sagittal location was classified as skin of the upper eyelid (a), subcutaneous tissue of the upper eyelid (b), skin of the lower eyelid (c), and subcutaneous tissue of the lower eyelid (d). C, Coronal location was classified as the upper eyelid margin (a), between the upper eyelid margin and eyebrow (b), the eyebrow (c), the lower eyelid margin (d), between the lower eyelid margin and cheek (e), and the cheek (f ). Table 1. Systemic Findings in 20 Patients With Eyelid Metastasis Patient No./ Sex/Age at Diagnosis, y Site of Primary Tumor Treatment of Primary Tumor Interval etween Diagnosis of Primary Tumor and Eyelid Metastasis, mo Diagnosis of Eyelid Metastasis efore Primary Tumor Nonocular Metastases at Time of Eyelid Metastasis Systemic Status (Time From Diagnosis, mo) 1/M/69 Skin melanoma Multiple excisional 96 No Skin, abdominal lymph Alive with metastasis (12) biopsies, CT nodes, and stomach 2/M/50 Skin melanoma Excisional biopsy, 8 No Neck lymph nodes Alive with metastasis (8) sentinel node biopsy 3/F/61 Skin melanoma Excisional biopsy, CT 34 No Liver, uterus, vagina, Dead of metastasis (4) brain, skin, parotid, and spine 4/M/33 Skin melanoma Excisional biopsy, CT 10 No None Dead of metastasis (36) 5/F/59 Uveal melanoma 125 I plaque radiotherapy 10 a Yes Liver, skin, and ribs Dead of metastasis (8) OD 6/M/60 Uveal melanoma Enucleation OS 31 No None Dead of metastasis (37) 7/F/52 Uveal melanoma Enucleation OS 34 No None Alive with metastasis (30) 8/F/52 Uveal melanoma Enucleation OS 54 No Liver and skin Dead of metastasis (1) 9/F/53 reast Mastectomy, CT 47 No Axillary lymph nodes Dead of metastasis (86) 10/F/62 reast Mastectomy, CT, ERT 9 No Axillary lymph nodes Dead of metastasis (27) 11/F/52 reast Mastectomy, CT 2 a Yes Axillary lymph nodes Dead of metastasis (54) 12/M/66 Renal cell carcinoma Nephrectomy, ERT, CT 15 No Lung, skin, and brain Dead of metastasis (4) 13/M/47 Renal cell carcinoma Nephrectomy, CT 33 No Skin, lung, ribs, Alive with metastasis (1) abdomen, and pelvis 14/F/67 Conjunctival melanoma OD Excisional biopsy, 88 No None Alive with metastasis (1) cryotherapy 15/F/81 Conjunctival melanoma OD Excisional biopsy, 145 No None Alive with metastasis (17) cryotherapy 16/F/58 Conjunctival melanoma OD Excisional biopsy, 16 No None Alive with metastasis (40) cryotherapy, 125 I plaque radiotherapy 17/M/56 Thyroid (MTC) Thyroidectomy, ERT 432 No Lung and cervical lymph Dead of metastasis (3) nodes 18/M/91 Prostate Prostatectomy, CT, 2 a Yes Submandibular lymph Dead of metastasis (21) orchiectomy nodes and lacrimal gland 19/F/57 Lung adenocarcinoma ERT, CT 6 No None Alive with metastasis (7) 20/M/74 Salivary gland adenocarcinoma Excisional biopsy 1 No Lymph nodes Alive with metastasis (1) Abbreviations: CT, chemotherapy; ERT, external beam radiotherapy; 125 I, iodine 125 (radioactive); MTC, medullary thyroid carcinoma; OD, right eye; OS, left eye. a Time interval for patients in whom eyelid metastasis was the first sign of a systemic primary tumor. The study included patients with eyelid metastasis from noncontiguous solid tumors. Patients who had orbital tumors or tumors that invaded the surrounding conjunctiva were excluded, as were patients with lymphoma because of multiorgan involvement. Internal review board approval at Wills Eye Institute was obtained. The data collected included information on the primary tumor and the eyelid metastasis. Primary tumor information included patient age at the time of diagnosis, the involved organ, and the primary tumor treatment (ie, surgical treatment, external beam radiotherapy [ERT], and chemotherapy). We evaluated the sites and management of associated nonocular systemic metastases and the interval between the diagnosis of the primary tumor and the eyelid metastasis (in months). The patients ages at the time of ocular diagnosis and symptoms were recorded. Ophthalmic data included laterality and best corrected Snellen visual acuity. Tumor data included the color (melanotic or amelanotic), number, maximum tumor di- 1000
3 A C D Figure 2. Examples of pigmented metastases from primary melanoma. A, Two pigmented metastases in the tarsal conjunctiva of the left upper eyelid from cutaneous melanoma in a man aged 33 years., Two small pigmented metastases on the medial aspect of the right upper and lower eyelids from uveal melanoma in a woman aged 59 years. C, Darkly pigmented nodule in the margin of the right upper eyelid corresponding to a metastasis from uveal melanoma in a woman aged 52 years. D, Photomicrograph from the patient in C showing infiltration of the eyelid dermis by metastatic melanoma cells. Inset shows melanoma cells (hematoxylin-eosin, original magnification 50 [main figure], 100 [inset]). mensions (in millimeters), and shape (sessile or pedunculated) of the tumor and the presence of other ocular metastases. The anatomic location of the eyelid metastasis was classified as follows: involved quadrant (upper eyelid, lower eyelid, or medial canthal or lateral canthal area [Figure 1A]); sagittal location (cutaneous or subcutaneous [Figure 1]); and coronal location (eyelid margin, eyebrow or cheek, or in between [Figure 1C]). The management of eyelid metastasis (surgical excision, ERT, chemotherapy, and observation) was recorded. Follow-up information was collected regarding visual acuity at the last visit, response to therapy (regression, recurrence, or stable or active disease), complications of therapy, and patient outcome (alive with metastasis, dead of metastasis, or dead of another cause). If there was a recurrence or development of a new eyelid metastasis, the location, date of the recurrence or new metastasis, and treatment were recorded. RESULTS From August 1977 through May 2008, 1773 patients had ocular metastasis, only 20 of whom (1.1%) had eyelid metastasis. The mean age at initial diagnosis of eyelid metastasis was 60 years (median, 60 years; range, years). There were 11 women (55%) and 9 men (45%). Nineteen patients were white and 1 was African American. Diagnosis of the eyelid metastasis was performed histopathologically in 16 patients (80%) and was based on clinical findings in 4 patients (20%) owing to widespread systemic disease. For each case, the primary tumor and its treatment are described in Table 1. In 17 patients with known primary tumors, eyelid metastasis developed a mean of 62.3 months after the diagnosis of the primary tumor (median, 33 months; range, months). In this group of patients, the primary tumors were skin melanoma (4 [20%]) (Figure 2), conjunctival melanoma (1 to the eyebrow and 2 to the area between the eyelid margin and the cheek of the lower eyelid [15%]), uveal melanoma (Figure 2) (3 [15%]), renal cell carcinoma (Figure 3) and breast carcinoma (2 [10%] each), and medullary thyroid carcinoma, lung adenocarcinoma (Figure 4), and salivary gland adenocarcinoma (Figure 5) (1 [5% each]). The eyelid metastasis was the initial manifestation of a cancer in 3 patients (15%). In these patients, subsequent systemic evaluation led to the diagnosis of a primary tumor, including prostate carcinoma, breast carcinoma, and uveal melanoma (1 [5%] each). The initial ocular symptom included a solitary eyelid nodule (12 [60%]), a flat pigmented lesion (3 [15%]), diffuse eyelid edema (3 [15%]), and epiphora and multiple eyelid nodules (1 [5%] each) (Table 2). The right 1001
4 A A Figure 3. Metastasis from renal cell carcinoma. A, Solitary metastasis in the right lower eyelid margin in a man aged 47 years., Photomicrograph from the same patient of a well-circumscribed nodule of metastatic renal cell carcinoma in the dermis of eyelid skin. Inset shows clear cell morphologic features of the tumor (hematoxylin-eosin, original magnification 10 [main figure], 100 [inset]). eye was involved in 12 patients (60%), the left eye in 6 patients (30%), and both eyes in 2 patients (10%). The eyelid metastasis was located in the superior eyelid in 7 patients (35%), the inferior eyelid in 6 patients (30%), the lateral canthal area in 3 patients (15%), the medial canthal area in 2 patients (10%), and both upper and lower eyelids in 2 patients (10%) (Figure 1A). The eyelid tumor was located along the palpebral margin in 5 patients (25%), the area between the eyelid margin and the eyebrow or the cheek in 10 patients (50%), in the eyebrow in 1 patient (5%), and in more than 1 of these locations in 4 patients (20%) (Figure 1). The metastasis involved only the skin in 2 patients (10%), only the subcutaneous tissue in 17 patients (85%), and both of these areas in 1 patient (5%) (Figure 1C). The eyelid mass was pigmented or dark in 10 patients (50%) and amelanotic in 10 patients (50%). The shape of the eyelid metastasis was sessile in 16 patients (80%) and pedunculated in 1 patient (5%) and showed diffuse infiltration in 3 patients (15%). The mean maximum basal diameter was 11 (median, 10; range, 1-25) mm. Seven patients had intrinsic vascularity (35%), and 2 patients had intralesional hemorrhages (10%). The mass was firm in 19 patients (95%) and soft in 1 patient (5%). None of the patients had ulceration of the eyelid skin. Overlying eyelash loss was found in 7 patients (35%). Figure 4. Metastasis from lung adenocarcinoma. A, Diffuse left lower eyelid mass and chemosis in a woman aged 57 years., Photomicrograph from the same patient shows infiltrating islands of poorly differentiated pulmonary adenocarcinoma. Mitotic figures (arrows) are evident in the inset (hematoxylin-eosin, original magnification 50 [main figure], 100 [inset]). Associated metastasis to the uvea was found in 6 patients (30%), to the orbit in 3 (15%), and to the conjunctiva in 2 (10%). Three patients (15%) had more than 1 eyelid metastatic tumor. Two of these patients had skin melanoma and 1 had uveal melanoma. In these patients, there were small, multiple melanotic eyelid tumors involving different parts of the eyelid. The initial management of the eyelid metastasis consisted of excisional biopsy alone (6 [30%]), ERT (7 [35%]), observation alone (3 [15%]), and systemic chemotherapy/immunotherapy (4 [20%]) (Table 2). There were no recurrences among the 6 patients who were treated initially with excisional biopsy alone (patients 6, 7, 13, 14, 15, and 16). Of the 7 patients who were treated with ERT, 3 tumors (43%) (patients 2, 9, and 18) showed regression, 3 tumors (43%) (patients 4, 12, and 19) were unresponsive, and 1 tumor (14%) (patient 20) remained stable. The tumor of one patient (14%) (patient 18) showed initial regression, with recurrence after 6 months of follow-up. This patient later underwent excisional biopsy followed by systemic chemotherapy with no response. Of the 4 patients who were treated with chemotherapy/immunotherapy, 1 tumor (25%) (patient 11) regressed, 1 tumor (25%) (patient 10) remained stable, and 2 tumors (50%) (patients 1 and 5) were unresponsive. Three tumors (15%) (patients 3, 8, and 17) were 1002
5 observed because of advanced systemic disease, and they remained stable. After a mean follow-up of 16 months (median, 10 months; range 1-48 months), 9 patients (45%) were alive and 11 (55%) had died of metastatic disease. Survival was 88%, 76%, 67%, and 67% at 3, 6, 9, and 12 months of follow-up, respectively. A COMMENT Figure 5. Metastasis from salivary gland adenocarcinoma. A, Diffuse mass in the right lower eyelid occluding the entire palpebral fissure in a man aged 74 years., Photomicrograph from the same patient shows infiltration of the dermis by metastatic salivary gland carcinoma. Arrow in inset denotes mucin vacuole in linear array of tumor cells (hematoxylin-eosin, original magnification 50 [main figure], 250 [inset]). Metastatic tumors rarely involve the eyelids. Ferry and Font 13 reviewed reports from an ocular pathology laboratory of 227 patients with ocular metastases and found that the most commonly affected ocular tissue was the choroid (112 [49%]), followed by the orbit (28 [12%]) and the iris and ciliary body (26 [11%]). The authors reported no eyelid metastases in that series. Similarly, in a postmortem survey of 230 autopsied eyes from patients with cancerrelated deaths, loch and Gartner 14 described ocular metastasis in 28 patients (12%), including 23 patients (10%) who had intraocular metastasis and 5 (2%) with orbital metastasis. No cases of eyelid involvement were mentioned in that series. Hutchison and Smith 15 described 100 patients with ocular metastasis from an ocular pathology laboratory. The most common ocular location was the choroid (63 [63%]), followed by the orbit (32 [32%]) and the ciliary body (6 [6%]). Three patients (3%) had eyelid metastasis. In our study, we reviewed 1773 cases of ocular metastasis from the ocular oncology service of a single institution and found 20 (1.1%) to have eyelid involvement. We have previously reported specific cases of eyelid metastasis from choroidal melanoma, prostate carcinoma, renal cell carcinoma, and medullary thyroid carcinoma. 5,6,8-10 Although eyelid metastasis usually appears in patients with a known systemic cancer, it can be the first symptom of systemic cancer or the first sign of metastasis from a known malignant neoplasm. In a series of 15 patients with eyelid metastases, Riley 11 reported that the eyelid metastasis was the first sign of systemic cancer in only 1 patient (7%). In the other 14 patients (93%), eyelid metastases were detected from 4 to 120 months after the diagnosis of the primary malignant neoplasm. In a histopathological review of 31 patients, Mansour and Hidayat 12 reported that eyelid metastasis was the first sign of systemic cancer in 14 patients (45%). In the other 17 patients (55%), eyelid metastases developed after a mean follow-up of 40 months (range, 2 weeks to 120 months). In our series, biopsy of the suspicious eyelid lesions led to the diagnosis of systemic cancer in 3 patients (15%). Immunohistochemistry is an essential tool for the ophthalmic pathologist dealing with an unknown primary tumor. Eyelid metastasis classically is associated with multiorgan, systemic, or other ocular tissue involvement. Riley 11 reported that associated multiorgan systemic metastases were found in 73% of patients, orbital metastasis in 33%, and choroidal metastasis in 7%. We observed associated multiorgan systemic metastases in 19 of our patients (95%) and ocular metastasis in 10 (50%). Patients with eyelid metastasis should have a full systemic evaluation and a detailed eye examination and orbital imaging. The features of eyelid metastasis at the initial examination are nonspecific. Metastases can manifest as solitary or multiple eyelid nodules or as diffuse eyelid swelling. In his review of 15 patients with eyelid metastases, Riley 11 reported that 7 patients (47%) had a solitary nodule, 6 (40%) had painless, diffuse eyelid swelling, and 2 (13%) had ulcerative lesions; multiple nodules were not found in any patient. Mansour and Hidayat 12 found that 22 of 31 patients (71%) had a solitary nodule, 4 (13%) had blepharoptosis, 2 (6%) had induration of the eyelid ( woody eyelid), and 2 (6%) had painless, diffuse eyelid swelling. ecause of the wide-spectrum presentation of eyelid metastases, the level of suspicion should be high, especially in patients with a history of systemic cancer. Any suspicious lesion should undergo biopsy. Morgan and associates 7 reviewed the literature to evaluate whether eyelid metastases from certain organs display specific clinical features. They reported that metastases from breast cancer tended to be painless diffuse eyelid swelling in 7 of 9 patients (78%), whereas those from lung cancer were solitary nodular lesions in all 4 patients (100%). In our study, breast and lung carcinoma showed no specific clinical manifestation. The only suggestive feature consisted of flat, multiple pigmented eyelid lesions in 3 of the 4 patients with cutaneous melanoma. Eyelid metastases are more common in middle-aged or older patients, although they can be seen in any age group. 1003
6 Table 2. Ocular Findings in 20 Patients With Eyelid Metastasis Patient No./Eye VA Ocular Symptom 1/OD 20/50 Flat pigmented lesions Location of Other Ocular Metastasis Eyelid Tumor Location No. of Tumors Quadrant Sagittal Coronal Local Treatment Tumor Status Systemic Status (Time From Diagnosis, mo) Conjunctiva Multiple Superior MCA and LCA Skin Multiple Systemic IT Progressive Alive with metastasis (12) ilateral choroid 1 Superior Skin In between a ERT OU Regressed Alive with metastasis (8) 2/OS 20/20 Flat pigmented lesion 3/OS 20/20 Nodule None 1 Superior Subcut In between a Observation Stable Dead of metastasis (4) 4/OU 20/20- Multiple Iris, choroid 5 Superior Subcut In between a ERT OU Progressive Dead of metastasis (36) 20/50 nodules 5/OU 20/20 Flat pigmented Caruncle OS 2 Superior Skin and Multiple Systemic CT, Progressive Dead of metastasis (8) lesions inferior subcut excisional biopsy 6/OD 20/20 Nodule None 1 Inferior Subcut In between a Excisional biopsy Regressed Dead of metastasis (37) 7/OD 20/20 Nodule None 1 Superior Subcut Margin Excisional biopsy Regressed Alive with metastasis (30) 8/OD 20/20 Nodule Choroid, orbit 1 Inferior Subcut In between a Observation Stable Dead of metastasis (1) OD 9/OS 20/20 Diffuse edema None 1 Inferior Subcut In between a ERT Regressed Dead of metastasis (86) 10/OS 20/20 Nodule None 1 Inferior Subcut Margin Systemic CT Stable Dead of metastasis (27) 11/OD 20/40 Nodule ilateral choroid 1 MCA Subcut Margin Systemic CT Regressed Dead of metastasis (54) 12/OS 20/40 Nodule None 1 Superior Subcut Margin ERT Progressive Dead of metastasis (4) 13/OD 20/20 Nodule None 1 LCA Subcut Margin Excisional biopsy Regressed Alive with metastasis (1) 14/OD 20/40 Nodule Choroidal mass 1 LCA Subcut In between a Excisional biopsy Regressed Alive with metastasis (1) 15/OD LP Nodule Orbit 1 Superior Subcut Eyebrow Excisional biopsy Regressed Alive with metastasis (17) 16/OD 20/70 Nodule None 1 LCA Subcut In between a Excisional biopsy Regressed Alive with metastasis (40) 17/OD 20/25 Nodule ilateral choroid 1 Superior Subcut In between a Observation Stable Dead of metastasis (3) 18/OD 20/25 Epiphora None 1 MCA Subcut In between a ERT, excisional Progressive b Dead of metastasis (21) biopsy, systemic CT 19/OS 20/60 Diffuse edema Orbit OS 1 Inferior Subcut In between a ERT, CT Progressive Alive with metastasis (7) and cheek 20/OD 20/100 Diffuse edema None 1 Inferior Subcut In between a and cheek ERT Stable Alive with metastasis (1) Abbreviations: CT, chemotherapy; ERT, external beam radiotherapy; IT, immunotherapy; LCA, lateral canthal area; LP, light perception; MCA, medial canthal area; OD, right eye; OS, left eye; OU, both eyes; subcut, subcutaneous; VA, visual acuity. a Indicates between the eyelid margin and the eyebrow or the cheek. b Patient 18 had initial regression of the tumor followed by recurrence after 6 months of follow-up. Table 3. Comparison of Frequency of Metastasis to Different Ocular Structures According to the Site of Origin: Findings From a Single Institution Site of Primary Tumor Eyelid Metastasis, No. (%) of Patients (n=20) Conjunctival Metastasis (n=10) a No. (%) of Patients Uveal Metastasis (n=420) b Orbital Metastasis (n=100) c reast 3 (15) 4 (40) 196 (46.7) 53 (53) Lung 1 (5) 2 (20) 90 (21.4) 8 (8) Gastrointestinal tract (4.3) 5 (5) Kidney 2 (10) 0 9 (2.1) 5 (5) Skin 4 (20) 2 (20) 9 (2.1) 6 (6) Prostate 1 (5) 0 9 (2.1) 12 (12) Choroid 4 (20) 0 3 (0.7) 2 (2) Parotid 1 (5) (1) Adrenal gland (0.2) 1 (1) Larynx 0 1 (10) 0 0 Thyroid 1 (5) 0 2 (0.5) 0 Lacrimal gland Conjunctiva 3 (15) Uterus (0.2) 0 Pancreas (0.7) 0 ladder (0.2) 0 Ovary (0.5) 0 Testis (0.2) 0 ile duct (0.2) 0 one (0.2) 0 Unknown 0 1 (10) 73 (17.4) 7 (7) a Kiratli et al. 19 b Shields et al. 16 c Shields et al
7 They have been reported in a 3-year-old child with embryonal carcinoma arising from the hip region. 12 Eyelid metastases are more often reported in women. 11,12 The most common primary systemic cancer is breast carcinoma, which accounts for 35% to 40% of patients with eyelid metastases. 11,12 Similarly, we have observed that the most common primary tumor for choroidal, orbital, and conjunctival metastasis is breast carcinoma (Table 3). In our study, cutaneous and uveal melanoma were the most common primary cancers. This could be related to the increasing incidence of cutaneous melanoma, to a referral bias toward our interest in melanoma, or to the biologic features of these tumors. The management of eyelid metastases includes excisional biopsy, ERT, systemic chemotherapy/immunotherapy, and observation. The clinical features of the tumor, such as the shape, number, and location of the metastases, and the systemic features play a role in the choice of treatment. A small, solitary nodular lesion can be managed with excisional biopsy. In general, ERT is used to treat patients with multiple eyelid metastases or recurrent lesions. If the patient is undergoing systemic chemotherapy/immunotherapy for widespread systemic disease, the tumor could be observed for response. Patients who are at the terminal stage and not receiving systemic treatment are generally observed. Newer therapies such as topical imiquimod have been used successfully as local treatment for patients with eyelid metastases from cutaneous melanoma. Patients with multiple metastases carry a worse prognosis, regardless of treatment. This may also be associated with the better prognosis in patients with single nodules that were excised (as the only treatment) and did not recur, compared with patients with multiple or large eyelid lesions who also had multiple metastases. CONCLUSIONS Eyelid metastasis can display a variety of clinical features and should be considered in patients with known systemic cancer. These patients usually have multiple metastatic sites, ocular and nonocular. We found that the most common primary malignant neoplasms to promote eyelid metastasis include skin and uveal melanoma (20% of the patients each), followed by breast carcinoma and conjunctival melanoma (15% of the patients each). Most of the patients (90%) were older than 50 years. Eyelid metastasis was the first sign of systemic cancer in 15% of patients, stressing the importance of histopathological examinations for all excised eyelid lesions. Ten patients (50%) had 2 concomitant ocular site metastases at the initial examination. Excision was successful in 100% of the patients with a solitary nodular lesion, ERT was successful in 43% of the patients with multiple nodular lesions, and systemic chemotherapy was successful in 50% of the patients with multiorgan involvement. Patients with eyelid metastasis have a poor systemic prognosis, and survival was 88%, 76%, 67%, and 67% at 3, 6, 9, and 12 months of follow-up, respectively. Submitted for Publication: September 24, 2008; final revision received November 28, 2008; accepted December 2, Correspondence: Carol L. Shields, MD, Ocular Oncology Service, Ste 1440, Wills Eye Institute, Thomas Jefferson University, 840 Walnut St, Philadelphia, PA (Carol.Shields@Shieldsoncology.Com). Financial Disclosure: None reported. Funding/Support: This study was supported by a donation from Michael, ruce, and Ellen Ratner (Drs J. A. Shields and C. L. Shields); Mellon Charitable Giving from the Martha W. Rogers Charitable Trust (Dr C. L. Shields); the Eye Tumor Research Foundation (Drs C. L. Shields and J. A. Shields); and the Noel T. and Sara L. Simmonds Endowment for Ophthalmic Pathology, Wills Eye Institute (Dr Eagle). REFERENCES 1. Aurora AL, lodi FC. Lesions of the eyelids: a clinicopathological study. Surv Ophthalmol. 1970;15(2): Arnold AC, ullock JD, Foos RY. Metastatic eyelid carcinoma. Ophthalmology. 1985;92(1): Wang JK, Liao SL, Jou JR, et al. Malignant eyelid tumours in Taiwan. Eye. 2003; 17(2): Weiner JM, Henderson PN, Roche J. Metastatic eyelid carcinoma. Am J Ophthalmol. 1986;101(2): Shields JA, Shields CL, Shakin EP, Kobetz LE. Metastasis of choroidal melanoma to the contralateral choroid, orbit, and eyelid. r J Ophthalmol. 1988; 72(6): Shields JA, Shields CL, Augsburger JJ, Negrey JN Jr. Solitary metastasis of choroidal melanoma to the contralateral eyelid. Ophthal Plast Reconstr Surg. 1987; 3(1): Morgan LW, Linberg JV, Anderson RL. Metastatic disease first presenting as eyelid tumors: a report of two cases and review of the literature. Ann Ophthalmol. 1987;19(1): Kindermann WR, Shields JA, Eiferman RA, Stephens RF, Hirsch SE. Metastatic renal cell carcinoma to the eye and adnexae: a report of three cases and review of the literature. Ophthalmology. 1981;88(12): Kaden IH, Shields JA, Shields CL, Rose LJ. Occult prostatic carcinoma metastatic to the medial canthal area: diagnosis by immunohistochemistry. Ophthal Plast Reconstr Surg. 1987;3(1): ianciotto CG, Demirci HY, Shields CL, Shields JA. Simultaneous eyelid and choroidal metastasis 36 years after diagnosis of medullary thyroid carcinoma. Ophthal Plast Reconstr Surg. 2008;24(1): Riley FC. Metastatic tumors of the eyelids. Am J Ophthalmol. 1970;69(2): Mansour AM, Hidayat AA. Metastatic eyelid disease. Ophthalmology. 1987;94(6): Ferry AP, Font RL. Carcinoma metastatic to the eye and orbit: a clinicopathologic study of 227 cases. Arch Ophthalmol. 1974;92(4): loch RS, Gartner S. The incidence of ocular metastatic carcinoma. Arch Ophthalmol. 1971;85(6): Hutchison DS, Smith TR. Ocular and orbital metastatic carcinoma. Ann Ophthalmol. 1979;11(6): Shields CL, Shields JA, Gross N, Schwartz G, Lally S. Survey of 520 eyes with uveal metastases. Ophthalmology. 1997;104(8): Shields CL, Shields JA. Metastatic tumors to the orbit. Int Ophthalmol Clin. 1993; 33(3): Shields JA, Shields CL, rotman HK, Carvalho C, Perez N, Eagle RC Jr. Cancer metastatic to the orbit: the 2000 Robert M. Curts Lecture. Ophthal Plast Reconstr Surg. 2001;17(5): Kiratli H, Shields CL, Shields JA, De Potter P. Metastatic tumors to the conjunctiva: report of 10 cases. r J Ophthalmol. 1996;80(1):
J of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 4/ Issue 55/ July 09, 2015 Page 9665
RARE PRESENTATION OF BILATERAL CHOROIDAL METASTASIS FROM PRIMARY MUCO-EPIDERMOID CARCINOMA OF THE PAROTID GLAND: A G. Premalatha 1, Ramya Seetamraju 2 HOW TO CITE THIS ARTICLE: G. Premalatha, Ramya Seetamraju.
More informationMetastasis of choroidal melanoma to the contralateral
British Journal of Ophthalmology, 1988, 72, 456-460 Metastasis of choroidal melanoma to the contralateral choroid, orbit, and eyelid* JERRY A SHIELDS,' CAROL L SHIELDS,' ERIC P SHAKIN,' AND LARRY E KOBETZ2
More informationPeriocular Malignancies
Periocular Malignancies Andrew Gurwood, O.D., F.A.A.O., Dipl. Marc Myers, O.D., F.A.A.O. Drs. Myers and Gurwood have no financial interests to disclose. Course Description Discussion of the most common
More informationOcular Neoplasia What s Common? What s New? Richard R Dubielzig
Ocular Neoplasia What s Common? What s New? Richard R Dubielzig Orbit 288 6% Tumors of the globe make up 3225 out of 6110 total neoplasms = 53%. Tumors of the conjunctiva make up 1192 out of 6110 total
More informationNasreen A. Syed, MD F.C. Blodi Eye Pathology Laboratory University of Iowa
Nasreen A. Syed, MD F.C. Blodi Eye Pathology Laboratory University of Iowa No financial disclosures No discussion of off-label use of medications or unapproved devices 67 year old male referred to Oculoplastics
More informationperformed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.
Hello, I am Maura Polansky at the University of Texas MD Anderson Cancer Center. I am a Physician Assistant in the Department of Gastrointestinal Medical Oncology and the Program Director for Physician
More informationClinical indications for positron emission tomography
Clinical indications for positron emission tomography Oncology applications Brain and spinal cord Parotid Suspected tumour recurrence when anatomical imaging is difficult or equivocal and management will
More informationPRIMARY OCULAR CARUNCULAR BASAL CELL CARCINOMA IN A CHINESE PATIENT
PRIMARY OCULAR CARUNCULAR BASAL CELL CARCINOMA IN A CHINESE PATIENT Chia-Ling Lee, 1 Shiuh-Liang Hsu, 1 and Cheng-Hsien Chang 2,3 1 Department of Ophthalmology, Kaohsiung Medical University Hospital, 2
More informationOcular Malignancies in the Elderly
Cancer Ocular Malignancies in the Elderly E. Rand Simpson, MD, Associate Professor of Ophthalmology, University of Toronto; Director, Ocular Oncology, Princess Margaret Hospital,Toronto, ON. Larry Ulanski
More informationCancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC
Cancers of unknown primary : Knowing the unknown Prof. Ahmed Hossain Professor of Medicine SSMC Definition Cancers of unknown primary site (CUPs) Represent a heterogeneous group of metastatic tumours,
More informationCutaneous metastases. Thaddeus Mully. University of California, San Francisco Professor, Departments of Pathology and Dermatology
Cutaneous metastases Thaddeus Mully University of California, San Francisco Professor, Departments of Pathology and Dermatology DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY Thaddeus Mully Course C005 Essential
More informationOriginal Articles Primary orbital melanoma in association with cellular blue nevus
Original Articles Primary orbital melanoma in association with cellular blue nevus Tarek El-Sawy, MD, PhD, a Mathieu F. Bakhoum, PhD, a Michael Tetzlaff, MD, PhD, b Qasiem J. Nasser, MD, a Victor G. Prieto,
More informationPlaque Radiotherapy in Recurrent or Incomplete- Excised Conjunctival Squamous Cell Carcinoma and Melanoma
Plaque Radiotherapy in Recurrent or Incomplete- Excised Conjunctival Squamous Cell Carcinoma and Melanoma Masood Naseripour, MD 1 Mohsen Bahmani-Kashkouli, MD 1 Ramin Jaberi, MS 2 Gholam-Hossein Aghaee,
More informationAnatomic Divisions. Ocular Surface. Intraocular. Orbital. Lacrimal. Eyelid
Anatomic Divisions Ocular Surface Intraocular Orbital Lacrimal Eyelid Ocular Surface Melanocytic Squamous Neoplasia Lymphoid Melanocytic Nevi PAM (Primary Acquired Melanosis) Ocular Melanocytosis Melanoma
More informationWe report the case of a 77-year-old woman in whom choroidal metastasis was the
CLINICOPATHOLOGIC REPORT Choroidal Metastasis as the Initial Manifestation of a Pigmented Neuroendocrine Tumor Ralph C. Eagle, Jr, MD; Hormoz Ehya, MD; Jerry A. Shields, MD; Carol L. Shields, MD We report
More informationWorld Articles of Ear, Nose and Throat Page 1
World Articles of Ear, Nose and Throat ---------------------Page 1 Primary Malignant Melanoma of the Tongue: A Case Report Authors: Nanayakkara PR*, Arudchelvam JD** Ariyaratne JC*, Mendis K*, Jayasekera
More informationDispelling Rumors about Tumors. Case
Dispelling Rumors about Tumors Jesse L. Berry, MD Arizona Ophthalmology Society 2017 Associate Director, Ocular Oncology Service Associate Program Director USC/CHLA, Keck School of Medicine Case 65 year
More informationRetina Center of Oklahoma Sam S. Dahr, M.D. Adult Intraocular Tumors
Adult Intraocular Tumors Sam S. Dahr, M.D. Retina Center of Oklahoma www.retinacenteroklahoma.com www.rcoklahoma.com Table of Contents Posterior uveal malignant melanoma Uveal metastasis Uveal melanoma
More informationSEER Summary Stage Still Here!
SEER Summary Stage Still Here! CCRA NORTHERN REGION STAGING SYMPOSIUM SEPTEMBER 20, 2017 SEER Summary Stage Timeframe: includes all information available through completion of surgery(ies) in the first
More informationPET/CT Frequently Asked Questions
PET/CT Frequently Asked Questions General Q: Is FDG PET specific for cancer? A: No, it is a marker of metabolism. In general, any disease that causes increased metabolism can result in increased FDG uptake
More informationDefinition of Synoptic Reporting
Definition of Synoptic Reporting The CAP has developed this list of specific features that define synoptic reporting formatting: 1. All required cancer data from an applicable cancer protocol that are
More informationAJCC 7th Edition Handbook Errata as of 9/21/10
5 81 Larynx ICD-O-3 Topography Codes Delete C32.3 Laryngeal cartilage 5 81 Larynx ICD-O-3 Topography Codes Add an asterisk after C32.8 5 81 Larynx ICD-O-3 Topography Codes Add an asterisk after C32.9 5
More informationCase Report Renal Cell Carcinoma Metastatic to Thyroid Gland, Presenting Like Anaplastic Carcinoma of Thyroid
Case Reports in Urology Volume 2013, Article ID 651081, 4 pages http://dx.doi.org/10.1155/2013/651081 Case Report Renal Cell Carcinoma Metastatic to Thyroid Gland, Presenting Like Anaplastic Carcinoma
More informationTake Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules
Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules Case 1 72 year old white female presents with a nodular thyroid. This was biopsied in
More informationOrbital Tumors - A Clinico Pathological Study
Orbital Tumors - A Clinico Pathological Study Radha. J. DO, Ani Sreedhar. MS. Little Flower Hospital, Angamaly, Kerala ORIGINAL ARTICLES Abstract: Aim. To study the clinical and histopathological profiles
More informationCase Rep Oncol 2012;5: DOI: /
This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the article
More informationAmong the benign intraepithelial melanocytic proliferations, Inflamed Conjunctival Nevi. Histopathological Criteria. Resident Short Reviews
Resident Short Reviews Inflamed conjunctival nevi (ICN) may suggest malignancy because of their rapid growth and atypical histology. The objective of this study was to characterize the diagnostic features
More informationSEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl
SEER Advanced Topic 2018 Presentation EOD 2018 and SS2018 Jennifer Ruhl May 25, 2018 Outline General overview of EOD Schemas Basic review of what is needed to collect Primary Tumor, Regional Nodes and
More informationCase Report Late Simultaneous Metastasis of Renal Cell Carcinoma to the Submandibular and Thyroid Glands Seven Years after Radical Nephrectomy
International Otolaryngology Volume 2010, Article ID 698014, 4 pages doi:10.1155/2010/698014 Case Report Late Simultaneous Metastasis of Renal Cell Carcinoma to the Submandibular and Thyroid Glands Seven
More informationInterventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies
Web appendix 2: SEARCH STRATEGIES Interventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies MEDLINE 1. exp epidemiologic studies/
More informationIntroduction. Results. Discussion. Histopathologic and immunohistochemical findings. Results. conclusions,
1/5 2/5 Carcinoma distinctive carcinoma. form erysipeloides (CE), metastasis. which clinically Itfrom has resembles been termed erysipelas, is an uncommon, but may extend It164 toclassically back, presents
More informationT of patients with malignant melanoma
~~ RADIOGRAPHIC: EVALUATION OF METASTATIC MELANOMA JACK E. MEYER, MD*+$ Malignant melanoma can potentially involve any organ system in the body once it metastasizes beyond the regional lymph nodes. A survey
More informationCase Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors
CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior
More informationPalpebral malignant tumors in the Albanian population
BRIEF COMMUNICATIONS Palpebral malignant tumors in the Albanian population Amarildo Belshi 1, Gjergji Belba 1 1 University Hospital Center Mother Teresa, Tirana, Albania. Corresponding author: Amarildo
More informationPeriocular skin cancer
Periocular skin cancer Information for patients Skin cancer involving the skin of the eyelid or around the eye is called a periocular skin cancer. Eyelid skin cancers occur most often on the lower eyelid,
More informationRadiology Pathology Conference
Radiology Pathology Conference Sharlin Johnykutty,, MD, Cytopathology Fellow Sara Majewski, MD, Radiology Resident Friday, August 28, 2009 Presentation material is for education purposes only. All rights
More informationCLINICAL PEARLS IN OCULAR ONCOLOGY
CLINICAL PEARLS IN OCULAR ONCOLOGY IRIS NEVUS - Two kinds circumscribed and diffuse - Photodocumentation important to monitor growth - Risk Factors for iris nevus growth to melanoma (ABCDEF) A Age (young),
More informationTransvitreal Fine Needle Aspiration Biopsy of Choroidal Melanoma via Pars Plana Vitrectomy
Surgical Technique Is pars plana vitrectomy a safe method for performing fine needle aspiration biopsy of choroidal melanoma? What are the rates of complications? Clinical Characteristics Do tumor thickness
More informationChapter 2 Staging of Breast Cancer
Chapter 2 Staging of Breast Cancer Zeynep Ozsaran and Senem Demirci Alanyalı 2.1 Introduction Five decades ago, Denoix et al. proposed classification system (tumor node metastasis [TNM]) based on the dissemination
More informationCharacteristic Ultrasonographic Findings of Choroidal Tumors
Characteristic Ultrasonographic Findings of Choroidal Tumors Tsung-Jen Wang, Chang-Hao Yang, Shu-Lang Liao, Tzyy-Chang Ho, Jen-Shang Huang, Chang-Ping Lin, Chung-May Yang, Muh-Shy Chen and Luke Long-Kuang
More informationCase Report Primary Neuroendocrine Carcinoma of Ocular Adnexa
Volume 2013, Article ID 281351, 4 pages http://dx.doi.org/10.1155/2013/281351 Case Report Primary Neuroendocrine Carcinoma of Ocular Adnexa Daisuke Yamanouchi, 1 Toshiyuki Oshitari, 1 Yosuke Nakamura,
More informationDisorders of Cell Growth & Neoplasia. Histopathology Lab
Disorders of Cell Growth & Neoplasia Histopathology Lab Paul Hanna April 2010 Case #84 Clinical History: 5 yr-old, West Highland White terrier. skin mass from axillary region. has been present for the
More informationManagement of Neck Metastasis from Unknown Primary
Management of Neck Metastasis from Unknown Primary.. Definition Histologic evidence of malignancy in the cervical lymph node (s) with no apparent primary site of original tumour Diagnosis after a thorough
More informationMaligna Melanoma and Atypical Fibroxanthoma: An Unusual Collision Tumour G Türkcü 1, A Keleş 1, U Alabalık 1, D Uçmak 2, H Büyükbayram 1 ABSTRACT
Maligna Melanoma and Atypical Fibroxanthoma: An Unusual Collision Tumour G Türkcü 1, A Keleş 1, U Alabalık 1, D Uçmak 2, H Büyükbayram 1 ABSTRACT Two different neoplasia in the same biopsy material called
More informationAmerican Journal of. Cancer Case Reports
American Journals of Cancer Case Reports http://ivyunion.org/index.php/ajccr/index Cancer Case Reports AK H et al. American Journal of Cancer Case Reports 2013, 1:93-97 Vol. 1, Article ID Page 201300216,
More informationIMAGING GUIDELINES - COLORECTAL CANCER
IMAGING GUIDELINES - COLORECTAL CANCER DIAGNOSIS The majority of colorectal cancers are diagnosed on colonoscopy, with some being diagnosed on Ba enema, ultrasound or CT. STAGING CT chest, abdomen and
More informationMalignant tumors of the eye and ocular adnexa in Thailand: a six-year review at King Chulalongkorn Memorial Hospital
Asian Biomedicine Vol. 3 No. 5 October 2009; 551-555 Brief communication (Original) Malignant tumors of the eye and ocular adnexa in Thailand: a six-year review at King Chulalongkorn Memorial Hospital
More informationOcular Neoplasia CL Davis 9/08. Richard R Dubielzig
Ocular Neoplasia CL Davis 9/08 Richard R Dubielzig 2135/5722 Canine Melanocytic Tumors Outside the Globe: 264 Conjunctival: 159 Eye Lid: 72 Skin: 33 Affecting the Globe: 1871 Anterior Uveal Melanocytoma:
More informationCase 18. M75. Excision of mass on scalp. Clinically SCC. The best diagnosis is:
Case 18 M75. Excision of mass on scalp. Clinically SCC. The best diagnosis is: A. Pilomatrical carcinoma B. Adnexal carcinoma NOS C. Metastatic squamous cell carcinoma D.Primary squamous cell carcinoma
More informationGene Expression Profiling has been proposed as a method of risk stratification for uveal melanoma.
Last Review Status/Date: September 2014 Description Page: 1 of 5 Gene Expression Profiling has been proposed as a method of risk stratification for uveal melanoma. Background Uveal melanoma Uveal melanoma,
More informationCURRENT ISSUES IN TRANSPLANT DERMATOLOGY
CURRENT ISSUES IN TRANSPLANT DERMATOLOGY NO CONFLICTS OF INTEREST TO DISCLOSE SOLID ORGAN TRANSPLANTATION: 2015 As of April 10, 2015.. 123,319 patients waiting for an organ transplant 2,557 performed this
More informationChecklist; Anus: Excisional Biopsy Anus: Excisional Biopsy 1/1/ Checklist; Anus: Resection Anus: Resection 1/1/2005
ChecklistTemplateVersions ChecklistTemplateVersion Ckey OfficialName VisibleText RevisionDate Checklist; Adrenal gland: 16.1000043 Resection Adrenal gland: Checklist; Ampulla of 17.1000043 Vater: Ampullectomy
More informationHistopathological Study of Lacrimal Gland Tumors
ORIGINAL ARTICLE Pratikkumar B. Desai 1, Ami Shah 2 1 4 th Year Resident, Pathology Department, B.J.Medical College, Civil Hospital, Ahmedabad 2 Associate Professor, M. J. Institute of Ophthalmology, Civil
More informationAsadi-Amoli et al Adenocarcinoma of RPE Iranian Journal of Ophthalmology - Volume 19, Number 4, 2007
Adenocarcinoma of Retinal Pigment Epithelium Clinically Diagnosed as Malignant Melanoma; A Case Report with Unsystematic Review of Literature Fahimeh Asadi-Amoli, MD, 1 Hedyeh Moradi, MD 2 Mohammad-Taher
More informationACTIVATED OR NOT? RETINAL CASE PRESENTATION Shorye Payne, MD Medical Retinal Specialist Robley Rex VA Eye Clinic
ACTIVATED OR NOT? RETINAL CASE PRESENTATION Shorye Payne, MD Medical Retinal Specialist Robley Rex VA Eye Clinic C We anticipate that the future management of posterior uveal melanoma (PUM) will focus
More informationPanMidlands Ocular Cancer Pathway March 2008 Approved by The Midland Oculoplastic Surgery Society
PanMidlands Ocular Cancer Pathway March 2008 Approved by The Midland Oculoplastic Surgery Society Periocular Skin Pathway Referrals to Oculoplastics Strong Indication: Lesion within orbital rim Medial
More informationSolitary Orbital Metastasis Presenting as Extraocular Muscle Mass in Lung Cancer Patient: A Case Report 외안근비대의형태로나타난폐암환자의고립성안와전이 : 증례보고
Case Report pissn 1738-2637 / eissn 2288-2928 https://doi.org/10.3348/jksr.2017.77.3.143 Solitary Orbital Metastasis Presenting as Extraocular Muscle Mass in Lung Cancer Patient: A Case Report 외안근비대의형태로나타난폐암환자의고립성안와전이
More informationcame from a carcinoma and in 12 from a sarcoma. Ninety lesions were intrapulmonary and the as the chest wall and pleura. Details of the primary
Thorax 1982;37:366-370 Thoracic metastases MARY P SHEPHERD From the Thoracic Surgical Unit, Harefield Hospital, Harefield ABSTRACI One hundred and four patients are reviewed who were found to have thoracic
More informationAdvances in Ocular Imaging
Wide angle fundus imaging and Fuorescein angiography in evaluation and management of intraocular tumors Ihab Saad Othman, MD, FRCS Professor of Ophthalmology Cairo University Cairo, Egypt Advances in Ocular
More informationSurveillance following treatment of primary ocular melanoma
Surveillance following treatment of primary ocular melanoma Introduction 50% of UM patients relapse with predominantly liver metastases Risk of metastatic disease can be predicted relatively accurately
More informationMEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site
POLICY: PG0364 ORIGINAL EFFECTIVE: 04/22/16 LAST REVIEW: 07/26/18 MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site GUIDELINES This policy does not certify benefits or authorization
More informationOncology 101. Cancer Basics
Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases
More informationA Case Report of Recurrent Conjunctival Squamous Cell Carcinoma M Zhao 1, W Lin 2 *, Z Liu 2 ABSTRACT
A Case Report of Recurrent Conjunctival Squamous Cell Carcinoma M Zhao 1, W Lin 2 *, Z Liu 2 ABSTRACT A case of recurrent squamous cell carcinoma of the conjunctiva is presented here. A 13-yearsold male
More informationJMSCR Vol 04 Issue 11 Page November 2016
The development of metastatic skin lesions is indicative of a poor prognosis and usually occurs with the presence of disseminated disease [4]. A retrospective study by Looking bill et al. showed a median
More informationMetachronic solitary breast metastasis from renal cell carcinoma: case report
Metachronic solitary breast metastasis from renal cell carcinoma: case report Abstract We describe the case of a patient with solitary and metachronic breast metastasis, 3 years after nephrectomy for renal
More informationFINALIZED SEER SINQ QUESTIONS
0076 Source 1: WHO Class CNS Tumors pgs: 33 MP/H Rules/Histology--Brain and CNS: What is the histology code for a tumor originating in the cerebellum and extending into the fourth ventricle described as
More informationMelanoma Case Scenario 1
Melanoma Case Scenario 1 History and physical 11/5/16 Patient is a single, 48-year-old male in good health who presented to his primary physician for a yearly physical exam during which a 3.4 x 2.8 x 1.5
More informationMALIGNANT TUMOURS OF THE JAWS
MALIGNANT TUMOURS OF THE JAWS MALIGNANT TUMOURS OF THE JAWS Squamous cell carcinoma Osteogenic sarcoma Chondrosarcoma Fibrosarcoma Malignant lymphomas (incl. Burkitt s) Multiple myeloma Ameloblastoma Secondary
More informationThe many faces of extranodal lymphoma
The many faces of extranodal lymphoma Frank Pameijer Departments of Radiology and Radiation Oncology University Medical Center Utrecht Special thanks to Ilona M Schmalfuss, MD University of Florida Gainesville,
More informationCase Presentation 主治醫師 : 宋文鑫日期 :
Case Presentation 主治醫師 : 宋文鑫日期 : 2015-2-28 General Data Name:OOO Chart Number:OOOOOOO Date of Admission:2014 年 08 月 04 日 Age: 33 y/o Sex:female Occupation : 會計 Chief Complaint Palpable soft tissue mass
More informationGreater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute
2008 ANNUAL REPORT Greater Baltimore Medical Center Sandra & Malcolm Berman Cancer Institute Cancer Registry Report The Cancer Data Management System/ Cancer Registry collects data on all types of cancer
More informationJournal of International Academy of Forensic Science & Pathology (JIAFP)
Journal of International Academy of Forensic Science & Pathology (JIAFP) ISSN 2395-0722 MICROCYSTIC ADNEXAL CARCINOMA-A CASE REPORT WITH REVIEW OF LITERATURE Case Report Sulakshana M S 1,Natarajan M 2
More informationNeoplasia part I. Dr. Mohsen Dashti. Clinical Medicine & Pathology nd Lecture
Neoplasia part I By Dr. Mohsen Dashti Clinical Medicine & Pathology 316 2 nd Lecture Lecture outline Review of structure & function. Basic definitions. Classification of neoplasms. Morphologic features.
More informationCase #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).
SOLID TUMORS WORKSHOP Cases for review Prostate Cancer Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ). January 2009 PSA 4.4, 20% free; August 2009 PSA 5.2; Sept 2009
More informationCLINICAL SCIENCES. Visual Acuity in 3422 Consecutive Eyes With Choroidal Nevus
CLINICAL SCIENCES Visual Acuity in 3422 Consecutive Eyes With Choroidal Nevus Carol L. Shields, MD; Minoru Furuta, MD; Arman Mashayekhi, MD; Edwina L. Berman, MBBS; Jonathan D. Zahler, DO; Daniel M. Hoberman,
More informationMelanoma Case Scenario 1
Melanoma Case Scenario 1 History and physical 11/5/16 Patient is a single, 48-year-old male in good health who presented to his primary physician for a yearly physical exam during which a 3.4 x 2.8 x 1.5
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES OCULAR ONCOLOGY PERIOCULAR CUTANEOUS MALIGNANCY Site Group: Ocular Periocular Cutaneous Malignancies Prepared by: Harmeet S. Gill MD, FRCSC
More informationMulti-Organ Distant Metastases in Follicular Thyroid Cancer- Rare Case Report
Multi-Organ Distant Metastases in Follicular Thyroid Cancer- Rare Case Report Dr. Mohammed Raza 1, Dr. Sindhuri K 2, Dr. Dinesh Reddy Y 3 1 Professor, Department of Surgery, JSS University, Mysore, India
More information42 yr old male with h/o Graves disease and prior I 131 treatment presents with hyperthyroidism and undetectable TSH. 2 hr uptake 20%, 24 hr uptake 50%
Pinhole images of the neck are acquired in multiple projections, 24hrs after the oral administration of approximately 200 µci of I123. Usually, 24hr uptake value if also calculated (normal 24 hr uptake
More informationNASAL SEPTUM ADENOID CYSTIC CARCINOMA: A CASE REPORT
NASAL SEPTUM ADENOID CYSTIC CARCINOMA: A CASE REPORT Shu-Yu Tai, 1 Chen-Yu Chien, 2 Chih-Feng Tai, 2,4 Wen-Rei Kuo, 2,4 Wan-Ting Huang, 3 and Ling-Feng Wang 2,4 Departments of 1 Family Medicine, 2 Otolaryngology
More informationCONFLUENCE - EYE AND BEYOND
Day 1, December 13, 2013 OCULOPLASTY Session 1, Instruction courses 1. Entropion and Ectropion - Refinements in Evaluation and Management 2. Enucleation, Evisceration and Exenteration - Practice Patterns
More informationTechnicians & Nurses Program
ASCRS ASOA Symposium & Congress Technicians & Nurses Program May 6-10, 2016 New Orleans Evaluation and Treatment of Eyelid Malignancies Richard C. Allen MD PhD FACS Professor Section of Ophthalmology Dept.
More informationCitation 泌尿器科紀要 (1981), 27(11):
Title METASTATIC URETHRAL TUMOR FROM CARC OF THE BREAST: A CASE REPORT Author(s) Tanaka, Yoichi; Okabe, Tatsushiro; Kiyiyama, Tadao; Yoshida, Osamu Citation 泌尿器科紀要 (1981), 27(11): 1393-1397 Issue Date
More informationAbstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 Final Pathology:
Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 A 74 year old male with a history of GERD presents complaining of dysphagia. An esophagogastroduodenoscopy
More informationRadiation Oncology MOC Study Guide
Radiation Oncology MOC Study Guide The following study guide is intended to give a general overview of the type of material that will be covered on the Radiation Oncology Maintenance of Certification (MOC)
More information2018 Grade PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018
1 2018 Grade PEGGY ADAMO, RHIT, CTR ADAMOM@MAIL.NIH.GOV OCTOBER 11, 2018 2 Acknowledgements Donna Hansen, CCR Jennifer Ruhl, NCI SEER Introduction 3 Histologic Type vs. Grade Credit: Dr. Kay Washington
More informationRosai-Dorfman disease (sinus histiocytosis with
Case Report 621 Disease Manifesting as Relapsing Uveitis and Subconjunctival Masses Hsin-Yuan Tan, MD; Ling-Yuh Kao, MD disease (sinus histiocytosis with massive lymphadenopathy, SHML) is a rare, non-hereditary,
More informationComplicated Cataract to Intraocular Tumors, Beware of the unexpected
Complicated Cataract to Intraocular Tumors, Beware of the unexpected Ihab Saad Othman, MD, FRCS Professor of Ophthalmology Cairo University In this part of the world: We Master Phakoemulsification 1 Intraoperative/Second
More informationExenteration. Introduction. The skin. Epidermal malignancies 8/3/2017. Neglected basal cell carcinoma
Jeremiah Tao, MD, FACS Director, Oculoplastic and Orbital Surgery Associate Professor, UC Irvine Neglected basal cell carcinoma Exenteration Introduction Chief question with any eyelid lesion: Suspicious
More informationCase Report: Chondroid Syringoma of the Cheek
Cronicon OPEN ACCESS Dina Amin 1 *, Abdullah Al-Gorashi 2 and Rahaf Y Al-Habbab 2 1 Assistant Consultant Al-Noor Specialist Hospital, Saudi Arabia, Clinical fellow University of Alabama, USA 2 Department
More informationPrimary cutaneous malignant melanoma of the breast
J Korean Surg Soc 2012;83:388-392 http://dx.doi.org/10.4174/jkss.2012.83.6.388 CASE REPORT JKSS Journal of the Korean Surgical Society pissn 2233-7903 ㆍ eissn 2093-0488 Primary cutaneous malignant melanoma
More informationأملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5
Leiomyosarcoma 1 / 5 EPIDEMIOLOGY Exact incidence is unknown, but older studies suggest that leiomyosarcomas comprise approximately 3 percent of soft-tissue sarcomas. Superficial leiomyosarcoma occurs
More informationOcular Anatomy for the Paraoptometric
Ocular Anatomy for the Paraoptometric Minnesota Optometric Association Paraoptometric CE Friday September 30, 2016 Lindsay A. Sicks, OD, FAAO Assistant Professor, Illinois College of Optometry lsicks@ico.edu
More informationMALIGNANT SALIVARY GLAND TUMOURS OF THE
Brit. J. Ophthal. (1963) 47, 279. MALIGNANT SALIVARY GLAND TUMOURS OF THE NASAL SINUSES AND EXOPHTHALMOS* BY ALY MORTADA Department of Ophthalmology, Faculty of Medicine Cairo University, Egypt TUMOURS
More information1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.
History and Physical Case Scenario 1 45 year old white male presents with complaints of nausea, weight loss, and back pain. A CT of the chest, abdomen and pelvis was done on 12/8/12 that revealed a 12
More informationCLINICAL SCIENCES. Acquired Tumors Arising From Congenital Hypertrophy of the Retinal Pigment Epithelium. well-known fundus condition
CLINICAL SCIENCES Acquired Tumors Arising From Congenital Hypertrophy of the Retinal Pigment Epithelium Jerry A. Shields, MD; Carol L. Shields, MD; Arun D. Singh, MD Background: Congenital hypertrophy
More information1. Written information to patient /GP: fax ASAP to GP & offer copy of consultation letter.
Skin Cancer follow up guidelines If NEW serious diagnosis given: 1. Written information to patient /GP: fax ASAP to GP & offer copy of consultation letter. 2. Free prescription information details. 3.
More informationCancer of lymph nodes survival rate
Cancer of lymph nodes survival rate Search 14-3-2016 Survival rates of pancreatic cancer are based on outcomes of people who've had the disease. Find the survival rates for pancreatic cancer here. 18-12-2017
More informationR. F. Falkenstern-Ge, 1 S. Bode-Erdmann, 2 G. Ott, 2 M. Wohlleber, 1 and M. Kohlhäufl Introduction. 2. Histology
Case Reports in Oncological Medicine Volume 2013, Article ID 167585, 4 pages http://dx.doi.org/10.1155/2013/167585 Case Report Late Lung Metastasis of a Primary Eccrine Sweat Gland Carcinoma 10 Years after
More information